Quick Heal Technologies Ltd Falls to 52-Week Low of Rs 158.3

Stock Price Movement and Market Context

On 2 March 2026, Quick Heal Technologies Ltd opened with a gap down of -3.67%, continuing its downward trajectory to hit an intraday low of Rs.158.3, representing a daily decline of -4.67%. This performance notably underperformed its sector by -3.11% on the same day. The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum.

In contrast, the broader market index, Sensex, despite opening sharply lower by 2,743.46 points, managed a partial recovery of 1,277.47 points to trade at 79,821.20, down by 1.8%. The Sensex remains below its 50-day moving average, though the 50DMA is positioned above the 200DMA, indicating mixed signals for the broader market.

Long-Term Price Performance

Over the past year, Quick Heal Technologies Ltd has delivered a return of -46.75%, significantly lagging behind the Sensex’s positive 9.05% gain. The stock’s 52-week high was Rs.416, highlighting the steep decline it has experienced in the last twelve months. This underperformance extends beyond the one-year horizon, with the stock also trailing the BSE500 index over the last three years, one year, and three months.

Financial Performance and Profitability Trends

Quick Heal Technologies Ltd’s financial metrics reveal a subdued growth trajectory. Net sales have declined at an annual rate of -1.02% over the last five years, while operating profit has deteriorated sharply by -178.20% in the same period. The company reported flat results in the December 2025 half-year, reflecting limited near-term growth momentum.

Profitability has also been under pressure, with profits falling by -74.2% over the past year. The company’s non-operating income for the quarter stands at 155.65% of profit before tax (PBT), indicating a reliance on income sources outside core operations to support profitability.

Liquidity and Efficiency Indicators

Liquidity measures show some constraints, with cash and cash equivalents at a low Rs.6.84 crores for the half-year period. The debtors turnover ratio is also at a low 1.57 times, suggesting slower collection cycles and potential working capital inefficiencies. Despite these concerns, the company maintains a low average debt-to-equity ratio of zero, indicating minimal leverage on its balance sheet.

Valuation and Risk Assessment

The stock is currently rated as a Strong Sell with a Mojo Score of 26.0, downgraded from Sell on 2 December 2025. Its market capitalisation grade stands at 3, reflecting its small-cap status within the Software Products sector. The stock’s valuation is considered risky compared to its historical averages, with negative EBITDA contributing to elevated risk perceptions among market participants.

Shareholding Pattern

The majority shareholding is held by promoters, which remains consistent with previous disclosures. This concentrated ownership structure may influence strategic decisions and market perceptions.

Summary of Key Concerns

The stock’s decline to Rs.158.3, its lowest level in 52 weeks, is underpinned by a combination of weak sales growth, deteriorating operating profits, and a significant drop in net earnings. The reliance on non-operating income to bolster profits and low liquidity levels further compound the challenges faced by Quick Heal Technologies Ltd. Its valuation metrics and negative EBITDA status contribute to a cautious outlook from a market perspective.

While the broader market has shown some resilience, Quick Heal Technologies Ltd’s performance remains subdued, with the stock trading well below all major moving averages and continuing to underperform its sector and benchmark indices.

Market Position and Sector Context

Operating within the Software Products industry, Quick Heal Technologies Ltd faces competitive pressures and market dynamics that have impacted its financial results and stock performance. The company’s current market cap grade of 3 reflects its relatively modest size compared to peers, which may influence its ability to capitalise on sector growth trends.

Conclusion

The recent fall to a 52-week low price of Rs.158.3 for Quick Heal Technologies Ltd encapsulates a period of sustained underperformance marked by declining sales, profitability pressures, and valuation concerns. The stock’s current metrics and market behaviour highlight the challenges faced by the company within its sector and broader market environment.

Only Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Start Today